Monoclonal antibodies in cancer therapy: 25 years of progress

被引：135

作者：

Oldham, Robert K. ^{[1
]}

Dillman, Robert O. ^{[2
]}

机构：

[1] New Mexico Canc Ctr, Gallup, NM USA

[2] Hoag Canc Ctr, Newport Beach, CA USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 11期

关键词：

D O I：

10.1200/JCO.2007.15.7438

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1774 / 1777

页数：4

共 37 条

[11]

DILLMAN RO, 1990, ANTIBODY IMMUNOCONJ, V3, P1

[12]

DILMAN RD, 2003, PRINCIPLES CANC BIOT, P329

[13] Prolonged treatment with rituximab in patients with follicular lymphoma significantly increases event-free survival and response duration compared with the standard weekly X 4 schedule [J].

Ghielmini, M ;

Schmitz, SFH ;

Cogliatti, SB ;

Pichert, G ;

Hummerjohann, J ;

Waltzer, U ;

Fey, MF ;

Betticher, DC ;

Martinelli, G ;

Peccatori, F ;

Hess, U ;

Zucca, E ;

Stupp, R ;

Kovacsovics, T ;

Helg, C ;

Lohri, A ;

Bargetzi, M ;

Vorobiof, D ;

Cerny, T .

BLOOD, 2004, 103 (12) :4416-4423

[14] Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: Results from the Eastern Cooperative Oncology Group Study E3200 [J].

Giantonio, Bruce J. ;

Catalano, Paul J. ;

Meropol, Neal J. ;

O'Dwyer, Peter J. ;

Mitchell, Edith P. ;

Alberts, Steven R. ;

Schwartz, Michael A. ;

Benson, Al B., III .

JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (12) :1539-1544

[15] Gemtuzumab ozogamicin in the treatment of acute myeloid leukemia [J].

Giles, F ;

Estey, E ;

O'Brien, S .

CANCER, 2003, 98 (10) :2095-2104

[16] FDA drug approval summary:: Panitumumab (Vectibix™) [J].

Giusti, Ruthann M. ;

Shastri, Kaushikkumar A. ;

Cohen, Martin H. ;

Keegan, Patricia ;

Pazdur, Richard .

ONCOLOGIST, 2007, 12 (05) :577-583

[17] Drug therapy: Trastuzumab - Mechanism of action and use in clinical practice [J].

Hudis, Clifford A. .

NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (01) :39-51

[18] Rituximab therapy of patients with B-cell chronic lymphocytic leukemia [J].

Huhn, D ;

von Schilling, C ;

Wilhelm, M ;

Ho, AD ;

Hallek, M ;

Kuse, R ;

Knauf, W ;

Riedel, U ;

Hinke, A ;

Srock, S ;

Serke, S ;

Peschel, C ;

Emmerich, B .

BLOOD, 2001, 98 (05) :1326-1331

[19] Current status of therapeutic vaccines for non-Hodgkin's lymphoma [J].

Hurvitz, SA ;

Timmerman, JM .

CURRENT OPINION IN ONCOLOGY, 2005, 17 (05) :432-440

[20] Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer [J].

Hurwitz, H ;

Fehrenbacher, L ;

Novotny, W ;

Cartwright, T ;

Hainsworth, J ;

Heim, W ;

Berlin, J ;

Baron, A ;

Griffing, S ;

Holmgren, E ;

Ferrara, N ;

Fyfe, G ;

Rogers, B ;

Ross, R ;

Kabbinavar, F .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (23) :2335-2342

← 1 2 3 4 →